Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
HC Wainwright & Co. analyst Swayampakula Ramakanth initiates coverage on Predictive Oncology (NASDAQ:POAI) with a Buy ra...
Predictive Oncology (NASDAQ:POAI) reported quarterly losses of $(0.68) per share. This is a 30.61 percent increase over losses ...
Findings demonstrate real-world applications of Company's AI platform to support biomarker discovery, clinical trial optimi...
Predictive Oncology Inc. (NASDAQ:POAI), a leader in AI-driven drug discovery and biologics, today announced that it has entered...
Predictive Oncology shares are blasting higher Thursday after the company announced it is expanding its AI and machine learning...
